Pulmonx Reports Record Fourth Quarter and Full Year 2024 Financial Results
Provided By GlobeNewswire
Last update: Feb 19, 2025
REDWOOD CITY, Calif., Feb. 19, 2025 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the "Company"), a global leader in minimally invasive treatments for lung disease, today reported financial results for the fourth quarter and full year ended December 31, 2024.
Read more at globenewswire.com
